OXYGENTA PHARMACEUTICAL LIMITE (OXYGENTAPH.BO)
INR 93.8
(1.99%)
INR 93.8
(1.99%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 396.42 Million | 309.87 Million | 605.24 Million | 520.27 Million | 137.16 Million | 205.07 Million |
| Cost of Revenue | 496.21 Million | 383.9 Million | 587.43 Million | 477.04 Million | 212.31 Million | 218.72 Million |
| Gross Profit | -99.79 Million | -74.03 Million | 17.81 Million | 43.22 Million | -75.15 Million | -13.65 Million |
| Operating Expenses | 23.78 Million | 17.54 Million | 18.84 Million | 16.62 Million | 13.42 Million | 16.39 Million |
| Selling, General and Administrative Expenses | 24.27 Million | 9.64 Million | 17.02 Million | 13.73 Million | 12.79 Million | 15.89 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -490 Thousand | -7.89 Million | -1.82 Million | -2.89 Million | -627.28 Thousand | -503.83 Thousand |
| Cost and Expenses | 519.99 Million | 401.45 Million | 606.28 Million | 493.67 Million | 225.74 Million | 235.12 Million |
| Operating Income | -123.57 Million | -91.57 Million | -1.03 Million | 26.59 Million | -88.57 Million | -30.04 Million |
| Interest Expense | 15.93 Million | 14.87 Million | 9.24 Million | 17.82 Million | 10.93 Million | 7.46 Million |
| Income Tax Expense | -103.92 Million | 1.98 Million | 1.21 Million | 2.13 Million | -1.53 Million | -2.39 Million |
| Earnings before Tax | -138.71 Million | -113.72 Million | -4.89 Million | 31.43 Million | -59.41 Million | -34.93 Million |
| Net Income | -34.79 Million | -115.7 Million | -6.1 Million | 29.29 Million | -57.88 Million | -32.54 Million |
| Earnings Per Share Basic | -1.04 | -8.15 | -0.43 | 2.87 | -5.67 | -3.19 |
| Earnings Per Share Diluted | -1.04 | -8.15 | -0.43 | 2.87 | -5.67 | -3.19 |
| Weighted Average Shares Outstanding | 33.48 Million | 14.2 Million | 14.2 Million | 10.2 Million | 10.2 Million | 10.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.48 Million | 14.2 Million | 14.2 Million | 10.2 Million | 10.2 Million | 10.2 Million |
| Gross Margin | -0.25 | -0.24 | 0.03 | 0.08 | -0.55 | -0.07 |
| EBIT Margin | -0.24 | -0.23 | 0.02 | 0.07 | -0.57 | -0.10 |
| Profit Margin | -0.09 | -0.37 | -0.01 | 0.06 | -0.42 | -0.16 |
| EBITDA | -96.17 Million | -78.33 Million | 20.26 Million | 61.22 Million | -38.48 Million | -17.28 Million |
| Earnings Before Tax Margin | -0.31 | -0.30 | -0.00 | 0.05 | -0.65 | -0.15 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 126.2 Million | 105.52 Million | 396.42 Million | 91.78 Million | 130.77 Million | 68.63 Million |
| Cost of Revenue | 140.82 Million | 113.37 Million | 496.21 Million | 119.59 Million | 156.85 Million | 106.38 Million |
| Gross Profit | -14.61 Million | -7.85 Million | -99.79 Million | -27.8 Million | -26.08 Million | -37.74 Million |
| Operating Expenses | 9.71 Million | 14.67 Million | 23.78 Million | 3.49 Million | 2 Million | 3.61 Million |
| Selling, General and Administrative Expenses | 9.71 Million | 14.67 Million | - | 3.49 Million | 2 Million | 3.61 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 150.53 Million | 128.04 Million | 519.99 Million | 123.09 Million | 158.85 Million | 109.99 Million |
| Operating Income | -24.32 Million | -22.52 Million | -123.57 Million | -31.3 Million | -28.08 Million | -41.35 Million |
| Interest Expense | 4.06 Million | 5.94 Million | 15.93 Million | 3.63 Million | 3.41 Million | 2.94 Million |
| Income Tax Expense | -14.53 Million | -106.02 Million | -103.92 Million | 2.3 Million | -199 Thousand | 1000.00 |
| Earnings before Tax | -28.17 Million | -25.87 Million | -138.71 Million | -31.25 Million | -31.79 Million | -45.58 Million |
| Net Income | -13.63 Million | 80.15 Million | -34.79 Million | -33.55 Million | -31.6 Million | -45.58 Million |
| Earnings Per Share Basic | -0.39 | 2.55 | - | -1.00 | -0.94 | -1.36 |
| Earnings Per Share Diluted | -0.39 | 2.44 | - | -1.00 | -0.94 | -1.36 |
| Weighted Average Shares Outstanding | 34.95 Million | 33.48 Million | 33.48 Million | 33.48 Million | 33.48 Million | 33.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.95 Million | 33.48 Million | 33.48 Million | 33.48 Million | 33.48 Million | 33.48 Million |
| Gross Margin | -0.12 | -0.07 | -0.25 | -0.30 | -0.20 | -0.55 |
| EBIT Margin | -0.14 | -0.15 | - | -0.27 | -0.15 | -0.53 |
| Profit Margin | -0.11 | 0.76 | -0.09 | -0.37 | -0.24 | -0.66 |
| EBITDA | -17.83 Million | -16.14 Million | - | -24.42 Million | -19.74 Million | -36.35 Million |
| Earnings Before Tax Margin | -0.19 | -0.21 | -0.31 | -0.34 | -0.21 | -0.60 |
SWF
RAMRAT
SGML
63MOONS
6805
4251